Patents by Inventor Shawnya Michaels

Shawnya Michaels has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180228813
    Abstract: The present disclosure provides oral dosage forms comprising a cephalotaxine and a pharmaceutically acceptable carrier selected from protein, carbohydrate and lipid, an oral dosage form comprising cephalotaxine and a second active agent, as well as methods of treating subjects with such oral formulations.
    Type: Application
    Filed: April 11, 2018
    Publication date: August 16, 2018
    Inventors: Dennis Brown, Shawnya Michaels
  • Publication number: 20160193223
    Abstract: The present disclosure provides oral dosage forms comprising a cephalotaxine and a pharmaceutically acceptable carrier selected from protein, carbohydrate and lipid, an oral dosage form comprising cephalotaxine and a second active agent, as well as methods of treating subjects with such oral formulations.
    Type: Application
    Filed: December 23, 2015
    Publication date: July 7, 2016
    Inventors: Dennis Brown, Shawnya Michaels
  • Publication number: 20110293676
    Abstract: The present disclosure provides oral dosage forms comprising a cephalotaxine and a pharmaceutically acceptable carrier selected from protein, carbohydrate and lipid, an oral dosage form comprising cephalotaxine and a second active agent, as well as methods of treating subjects with such oral formulations.
    Type: Application
    Filed: August 11, 2011
    Publication date: December 1, 2011
    Applicant: ChemGenex Pharmaceuticals, Inc.
    Inventors: Dennis BROWN, Shawnya MICHAELS
  • Publication number: 20090068236
    Abstract: The present disclosure provides oral dosage forms comprising a cephalotaxine and a pharmaceutically acceptable carrier selected from protein, carbohydrate and lipid, an oral dosage form comprising cephalotaxine and a second active agent, as well as methods of treating subjects with such oral formulations.
    Type: Application
    Filed: April 14, 2008
    Publication date: March 12, 2009
    Applicant: ChemGenex Pharmaceuticals, Inc.
    Inventors: Dennis Brown, Shawnya Michaels